261 related articles for article (PubMed ID: 15370691)
1. Risk of extra-oesophageal malignancies and colorectal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
Solaymani-Dodaran M; Logan RF; West J; Card T; Coupland C
Scand J Gastroenterol; 2004 Jul; 39(7):680-5. PubMed ID: 15370691
[TBL] [Abstract][Full Text] [Related]
2. Risk of oesophageal cancer in Barrett's oesophagus and gastro-oesophageal reflux.
Solaymani-Dodaran M; Logan RF; West J; Card T; Coupland C
Gut; 2004 Aug; 53(8):1070-4. PubMed ID: 15247170
[TBL] [Abstract][Full Text] [Related]
3. Mortality associated with Barrett's esophagus and gastroesophageal reflux disease diagnoses-a population-based cohort study.
Solaymani-Dodaran M; Logan RF; West J; Card T
Am J Gastroenterol; 2005 Dec; 100(12):2616-21. PubMed ID: 16393209
[TBL] [Abstract][Full Text] [Related]
4. Risk of Barrett's oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications.
Ladanchuk TC; Johnston BT; Murray LJ; Anderson LA;
Scand J Gastroenterol; 2010 Dec; 45(12):1397-403. PubMed ID: 20626305
[TBL] [Abstract][Full Text] [Related]
5. Gastro-oesophageal reflux symptoms, oesophagitis and Barrett's oesophagus in the general population: the Loiano-Monghidoro study.
Zagari RM; Fuccio L; Wallander MA; Johansson S; Fiocca R; Casanova S; Farahmand BY; Winchester CC; Roda E; Bazzoli F
Gut; 2008 Oct; 57(10):1354-9. PubMed ID: 18424568
[TBL] [Abstract][Full Text] [Related]
6. Dietary inflammatory index and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.
Shivappa N; Hebert JR; Anderson LA; Shrubsole MJ; Murray LJ; Getty LB; Coleman HG
Br J Nutr; 2017 May; 117(9):1323-1331. PubMed ID: 28571591
[TBL] [Abstract][Full Text] [Related]
7. The extent of oesophageal acid exposure overlap among the different gastro-oesophageal reflux disease groups.
Shapiro M; Green C; Faybush EM; Esquivel RF; Fass R
Aliment Pharmacol Ther; 2006 Jan; 23(2):321-9. PubMed ID: 16393313
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiological characteristics of the various forms of gastro-oesophageal reflux disease. Spectrum disease or distinct phenotypic presentations?
Frazzoni M; Manno M; De Micheli E; Savarino V
Dig Liver Dis; 2006 Sep; 38(9):643-8. PubMed ID: 16627016
[TBL] [Abstract][Full Text] [Related]
9. Multivariate analysis of the association of acid and duodeno-gastro-oesophageal reflux exposure with the presence of oesophagitis, the severity of oesophagitis and Barrett's oesophagus.
Koek GH; Sifrim D; Lerut T; Janssens J; Tack J
Gut; 2008 Aug; 57(8):1056-64. PubMed ID: 18403496
[TBL] [Abstract][Full Text] [Related]
10. Barrett's oesophagus: a clinical study of 52 patients.
Cooper BT; Barbezat GO
Q J Med; 1987 Feb; 62(238):97-108. PubMed ID: 3498962
[TBL] [Abstract][Full Text] [Related]
11. Adenocarcinoma and Barrett's oesophagus. A clinico-pathological study.
Moghissi K; Sharpe DA; Pender D
Eur J Cardiothorac Surg; 1993; 7(3):126-31. PubMed ID: 8461144
[TBL] [Abstract][Full Text] [Related]
12. [Quantification of gastro-esophageal reflux in Barrett's esophagus].
Ortiz Escandell A; Martínez de Haro LF; Parrilla Paricio P; Molina Martínez J; Aguayo Albasini JL; Martínez Gómez D
Rev Esp Enferm Dig; 1990 Mar; 77(3):171-5. PubMed ID: 2378753
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of Barrett's oesophagus (clinical): LOS dysfunction, hiatal hernia, peristaltic defects.
Roman S; Kahrilas PJ
Best Pract Res Clin Gastroenterol; 2015 Feb; 29(1):17-28. PubMed ID: 25743453
[TBL] [Abstract][Full Text] [Related]
14. Dietary magnesium, calcium:magnesium ratio and risk of reflux oesophagitis, Barrett's oesophagus and oesophageal adenocarcinoma: a population-based case-control study.
Dai Q; Cantwell MM; Murray LJ; Zheng W; Anderson LA; Coleman HG;
Br J Nutr; 2016 Jan; 115(2):342-50. PubMed ID: 26563986
[TBL] [Abstract][Full Text] [Related]
15. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
[TBL] [Abstract][Full Text] [Related]
16. Barrett's oesophagus and oesophageal adenocarcinoma: how does acid interfere with cell proliferation and differentiation?
Fitzgerald RC
Gut; 2005 Mar; 54 Suppl 1(Suppl 1):i21-6. PubMed ID: 15711004
[TBL] [Abstract][Full Text] [Related]
17. [Oesophageal diseases: gastroesophageal reflux disease, Barrett's disease, achalasia and eosinophilic oesophagitis].
Calvet X
Gastroenterol Hepatol; 2015 Sep; 38 Suppl 1():49-55. PubMed ID: 26520196
[TBL] [Abstract][Full Text] [Related]
18. Review article: management of oesophageal adenocarcinoma -- control of acid, bile and inflammation in intervention strategies for Barrett's oesophagus.
Jankowski JA; Anderson M
Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 5():71-80; discussion 95-6. PubMed ID: 15456468
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the magnitude of gastro-oesophageal reflux in Barrett's oesophagus.
Parrilla P; Ortiz A; Martinez de Haro LF; Aguayo JL; Ramirez P
Gut; 1990 Sep; 31(9):964-7. PubMed ID: 2210462
[TBL] [Abstract][Full Text] [Related]
20. Systematic review with meta-analysis: risk factors for Barrett's oesophagus in individuals with gastro-oesophageal reflux symptoms.
Eusebi LH; Telese A; Cirota GG; Haidry R; Zagari RM; Bazzoli F; Ford AC
Aliment Pharmacol Ther; 2021 May; 53(9):968-976. PubMed ID: 33705573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]